NUMOTIZINE

Dosage form: ointment
Ingredients: MENTHOL 1.25g in 100g
Labeler: Hobart Laboratories, Inc.
NDC code: 10546-100

Medically reviewed by Drugs.com. Last updated on Sep 6, 2024.

NUMOTIZINE OINTMENT

Active Ingredients

Menthol 1.25%

Purpose

Topical Analgesic

Inactive ingredients

Clay, Color, Fragrance of Guaiacol, Methyl Guaiacol and Oil of Wintergreen, Polyols.

Directions

Stir in any liquid at top of jar. Keep sealed when not in use.

Spread 1/8" to 1/4" of ointment to the skin. Cover the ointment with a cloth or bandage to protect clothing. Remove with warm water before totally dry (usually 8 to 12 hours). Application may be repeated every 12 hours as needed.

Uses

For use as a topical analgesic

Provides temporary relief of muscle pain, soreness and stiffness
Temporary pain relief on strains, sprains, ligament and tendon injuries
Arthritis

Stop use and ask a doctor if

Excessive irritation of the skin occurs.
Persistent swellings.

Keep out of the reach of children

Warnings:

For external use only.

Use only as directed. Avoid contact with eyes and mucous memebranes.

Do not apply to irritated or broken skin or to large areas of the body.

Representative Labeling For - Numotizine Ointment 3.5oz/99g (10546-100-35) | Numotizine Ointment 8oz/228g (10546-100-08)

Package Labeling:

NUMOTIZINE
menthol ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:10546-100
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
MENTHOL (MENTHOL)	MENTHOL	1.25 g in 100 g

Inactive Ingredients
Ingredient Name	Strength
KAOLIN
GUAIACOL
CREOSOL
METHYL SALICYLATE
PROPYLENE GLYCOL

Packaging
#	Item Code	Package Description
1	NDC:10546-100-35	99 g in 1 JAR
2	NDC:10546-100-08	228 g in 1 JAR

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part348	11/30/2011

Labeler - Hobart Laboratories, Inc. (005111786)

Registrant - Hobart Laboratories, Inc. (005111786)

Establishment
Name	Address	ID/FEI	Operations
Hobart Laboratories, Inc.		005111786	manufacture(10546-100)

Revised: 09/2019

Document Id: 92acc611-a1dc-93a7-e053-2a95a90aca4a

Set id: 9a29ad1b-4ba3-403f-90c9-ee7582fe4535

Version: 6

Effective Time: 20190916

Hobart Laboratories, Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

NUMOTIZINE

Further information

See also:

Qulipta

Aimovig

Dupixent

Gemtesa

Ubrelvy

Nurtec ODT

Xeomin

Tazarotene topical

Topiramate

Dysport